ASD and Oncology Supply: Entertainment for the People Buying the Drugs

The ASD Oncology Supply conference kickbacks case ended in a $1 million settlement over allegations that meals, alcohol and entertainment induced specialty-drug purchases. The audience included healthcare providers and medical-practice executives. The government alleged that the benefits led to false Medicare and Medicaid claims, putting the restaurant bill, the drug order and the physician’s claim in the same story. The alleged cost reached the public programs paying for the drugs.

ASD Specialty Healthcare does business as Oncology Supply Company, a specialty pharmaceutical distributor. It is a subsidiary of Cencora, formerly AmerisourceBergen. The Justice Department announced the settlement on March 6, 2026. This pharmaceutical kickback case reaches into the commercial relationship between a distributor and the practices buying its products.

What ASD Admitted About the Conference Benefits

ASD admitted that employees of Oncology Supply and International Oncology Network provided meals, alcohol and entertainment to health care providers and medical-practice executives at conferences. International Oncology Network, known as ION, is another Cencora subsidiary. It hosted the conferences for members of its Large Practice Program from January 2012 through October 2019.

The benefits included meals and alcohol at high-end restaurants, rounds of golf and outings at bars and nightclubs. Both the host’s employees and the distributor’s employees supplied the hospitality. The conference brought members together, and the company selling specialty drugs to practices was involved in entertaining them.

The government’s account also reaches beyond the conference setting. From January 2012 through September 2022, ASD paid for similar meals, alcohol and entertainment through 15 Oncology Supply and ION employees outside conferences. At some events, the company covered the expenses of providers’ and practice executives’ spouses too. The benefits reached beyond the people doing business with the distributor.

The same customer relationship can appear in an event budget and in expenses incurred away from the meeting.

The Purchasing Relationship Behind the Invitation

A specialty-drug distributor has a commercial interest in the practice’s purchasing decisions. The pharmaceutical supply chain moves products from manufacturers through wholesalers to dispensers, while contracts and payments follow their own paths. Here, the government alleged that the company supplying the drugs paid personal benefits to people on the buying side of that chain.

The government named medical-practice executives alongside providers and alleged that the benefits were intended to induce purchases from Oncology Supply. Its account puts the buying relationship at the center of the case. An insider may understand who controlled that relationship even when an expense entry says only dinner or golf.

There is a competitive cost to buying influence this way. The Journal of AHIMA review puts the harm to honest competitors alongside the harm to medical decisions:

A supplier competing on price and service has a different offer from one paying personal expenses for the people choosing where to buy.

How Do Pharmaceutical Kickbacks Work?

In this case, the government alleged that hospitality induced specialty-drug purchases and that ASD caused physicians to submit false claims to Medicare and Medicaid. The alleged connection runs from the distributor’s benefit, through the practice’s purchasing decision, to the physician’s government bill.

That last step explains why a distributor’s entertainment spending became a False Claims Act case. The government alleged that ASD caused the false claims and identified physicians as the people submitting them.

The practical question is what connects those participants. A person reviewing expenses may know who received a benefit and who approved it. Someone working on an account may know what purchases the company expected in return. The practice’s billing records concern the government-payment end of that relationship. We work with insiders to connect those views of the same business.

The Same Hospitality Problem in Speaker Programs

The speaker-program cases show another way hospitality and drug business can meet. Novartis admitted in its July 1, 2020 settlement that some sales representatives intended speaking fees to induce more prescriptions. It repeatedly paid for the same groups of doctors to dine together, sometimes rotating who received the speaking fee. It also paid doctors for purported speaking events that never happened.

In one admitted example, a Novartis sales representative arranged fake restaurant receipts, then used the dinner budget to buy gift cards for high-prescribing doctors. The recipients also received honoraria for the supposed talks.

In ASD’s case, the government focused on specialty-drug purchasing and hospitality for providers and practice executives. In the Novartis admissions, the sales objective appeared in speaking payments and repeated dinners. For an insider, the useful connection is between the company’s spending and the business it wanted the recipient to generate.

Another Distributor Benefit: Free Inventory Systems

ASD Specialty Healthcare also settled a separate case over benefits offered through its Besse Medical business. The Justice Department’s December 13, 2024 announcement described a $1.67 million settlement over allegations that it furnished free PODIS inventory management systems to induce drug purchases.

The alleged benefit there was a system the practice used, rather than a restaurant meal or a golf outing. The commercial connection was the same one the government alleged in the conference case: a distributor offering something of value to influence where a practice bought drugs. An insider’s knowledge of the purchasing relationship matters in either setting.

What Evidence Is Needed to Prove Fraud?

For a conference-benefit case, the useful evidence connects the benefit, its recipient, the purchasing purpose and the government claim. We examine how those pieces fit with what you saw inside the distributor, the conference operation or the practice.

You know what an account plan or an expense approval meant inside the business. We bring that knowledge together with the purchasing and billing records to assess the case with you.

An event coordinator, account employee or practice manager may see a different part of the arrangement. Who requested the outing, who approved a spouse’s expenses and what business was discussed can give meaning to an otherwise ordinary expense description. Our work is to build that account into a specific case with you.

The Settlement and the Whistleblower’s Share

The ASD settlement included claims brought through a qui tam case under the False Claims Act. The Justice Department announced that the whistleblower would receive an 18% share of the settlement.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Know the Account Behind the Entertainment

If you know the expense approvals and account plans behind a distributor’s entertainment spending, speak to one of our whistleblower experts about the drug purchases it was meant to win. We build your strongest pharmaceutical kickback whistleblower case with you, bring in whistleblower lawyers who understand distribution and practice purchasing, and stay beside you through the pursuit of a recovery.